Max Robotics — Global Service Robot Directory + US Certification

About

Hideji Tajima is a researcher whose work sits at the intersection of biomedical diagnostics, laboratory automation, and molecular biology. Over the course of his career, Tajima has made meaningful contributions to the development of automated analytical systems designed to improve the reliability and throughput of clinical and genomic testing. His most influential work, a 2019 study on lectin bead array technology (15 citations), introduced a fully automated glycoprotein profiling system capable of detecting disease-associated glycan alterations — a significant step toward more sensitive in vitro diagnostic tools. This builds on his earlier efforts automating complex biochemical assays, including a 2005 study improving lectin-antibody enzyme immunoassay of alphafetoprotein-L3, a key liver cancer biomarker, making it compatible with robotic platforms. Tajima's expertise in paramagnetic bead handling — embodied in his proprietary "Magtration" technology — underpins several of his contributions, including automated cycle sequencing (2003) and SNP genotyping workflows (2007). These systems addressed longstanding challenges in sample throughput and reproducibility in genomic analysis. Across his body of work, Tajima demonstrates a consistent commitment to translating emerging omics technologies into practical, automation-ready clinical tools, making laboratory diagnostics faster, more accurate, and more accessible.